BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
1425528	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H43FN4O3/c33-25-19-26(36-16-12-34-13-17-36)21-29(20-25)39-27-9-14-37(15-10-27)32(38)24-6-7-31(40-28-8-11-35-22-28)30(18-24)23-4-2-1-3-5-23/h6-7,18-21,23,27-28,34-35H,1-5,8-17,22H2/p+2	KERGUDBBTHPPMM-UHFFFAOYSA-P	682657	US20240208940, Example 1	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<60000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682657	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682657&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			162493398	503272077							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425529	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H43FN4O3/c33-25-19-26(36-16-12-34-13-17-36)21-29(20-25)39-27-9-14-37(15-10-27)32(38)24-6-7-31(40-28-8-11-35-22-28)30(18-24)23-4-2-1-3-5-23/h6-7,18-21,23,27-28,34-35H,1-5,8-17,22H2/p+2	KERGUDBBTHPPMM-UHFFFAOYSA-P	682657	US20240208940, Example 1	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<50000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682657	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682657&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			162493398	503272077							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425530	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CC2(C1)CC[NH2+]CC2 |r|	InChI=1S/C35H47FN4O3/c36-27-19-28(40-23-35(24-40)11-14-37-15-12-35)21-31(20-27)42-29-9-16-39(17-10-29)34(41)26-6-7-33(43-30-8-13-38-22-30)32(18-26)25-4-2-1-3-5-25/h6-7,18-21,25,29-30,37-38H,1-5,8-17,22-24H2/p+2	PXIDXDQBKKUSTR-UHFFFAOYSA-P	682658	US20240208940, Example 2	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			>100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682658	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682658&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055885	503272078							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425531	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CC2(C1)CC[NH2+]CC2 |r|	InChI=1S/C35H47FN4O3/c36-27-19-28(40-23-35(24-40)11-14-37-15-12-35)21-31(20-27)42-29-9-16-39(17-10-29)34(41)26-6-7-33(43-30-8-13-38-22-30)32(18-26)25-4-2-1-3-5-25/h6-7,18-21,25,29-30,37-38H,1-5,8-17,22-24H2/p+2	PXIDXDQBKKUSTR-UHFFFAOYSA-P	682658	US20240208940, Example 2	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		>84000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682658	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682658&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055885	503272078							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425532	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CCC2(C[NH2+]C2)CC1 |r|	InChI=1S/C35H47FN4O3/c36-27-19-28(39-16-11-35(12-17-39)23-38-24-35)21-31(20-27)42-29-9-14-40(15-10-29)34(41)26-6-7-33(43-30-8-13-37-22-30)32(18-26)25-4-2-1-3-5-25/h6-7,18-21,25,29-30,37-38H,1-5,8-17,22-24H2/p+2	YASVMCFEHWYVPC-UHFFFAOYSA-P	682659	US20240208940, Example 3	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			>100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682659	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682659&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055886	503272079							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425533	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CCC2(C[NH2+]C2)CC1 |r|	InChI=1S/C35H47FN4O3/c36-27-19-28(39-16-11-35(12-17-39)23-38-24-35)21-31(20-27)42-29-9-14-40(15-10-29)34(41)26-6-7-33(43-30-8-13-37-22-30)32(18-26)25-4-2-1-3-5-25/h6-7,18-21,25,29-30,37-38H,1-5,8-17,22-24H2/p+2	YASVMCFEHWYVPC-UHFFFAOYSA-P	682659	US20240208940, Example 3	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		>84000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682659	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682659&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055886	503272079							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425534	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1C[C@@H]2C[NH2+]C[C@@H]2C1 |r|	InChI=1S/C34H45FN4O3/c35-27-15-28(39-21-25-18-37-19-26(25)22-39)17-31(16-27)41-29-9-12-38(13-10-29)34(40)24-6-7-33(42-30-8-11-36-20-30)32(14-24)23-4-2-1-3-5-23/h6-7,14-17,23,25-26,29-30,36-37H,1-5,8-13,18-22H2/p+2	ZKPQVMMRDYGEDG-UHFFFAOYSA-P	682660	US20240208940, Example 4	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			>100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682660	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682660&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055887	503272080							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425535	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1C[C@@H]2C[NH2+]C[C@@H]2C1 |r|	InChI=1S/C34H45FN4O3/c35-27-15-28(39-21-25-18-37-19-26(25)22-39)17-31(16-27)41-29-9-12-38(13-10-29)34(40)24-6-7-33(42-30-8-11-36-20-30)32(14-24)23-4-2-1-3-5-23/h6-7,14-17,23,25-26,29-30,36-37H,1-5,8-13,18-22H2/p+2	ZKPQVMMRDYGEDG-UHFFFAOYSA-P	682660	US20240208940, Example 4	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		>84000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682660	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682660&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055887	503272080							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425536	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CCC2(C[NH2+]C2)CC1	InChI=1S/C35H47FN4O3/c36-27-19-28(39-16-11-35(12-17-39)23-38-24-35)21-31(20-27)42-29-9-14-40(15-10-29)34(41)26-6-7-33(43-30-8-13-37-22-30)32(18-26)25-4-2-1-3-5-25/h6-7,18-21,25,29-30,37-38H,1-5,8-17,22-24H2/p+2	YASVMCFEHWYVPC-UHFFFAOYSA-P	682661	US20240208940, Example 5	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<40000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682661	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682661&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055886	503272081							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425537	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CCC2(C[NH2+]C2)CC1	InChI=1S/C35H47FN4O3/c36-27-19-28(39-16-11-35(12-17-39)23-38-24-35)21-31(20-27)42-29-9-14-40(15-10-29)34(41)26-6-7-33(43-30-8-13-37-22-30)32(18-26)25-4-2-1-3-5-25/h6-7,18-21,25,29-30,37-38H,1-5,8-17,22-24H2/p+2	YASVMCFEHWYVPC-UHFFFAOYSA-P	682661	US20240208940, Example 5	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<40000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682661	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682661&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055886	503272081							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425538	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(OC3CC[NH2+]CC3)c(c2)C2CCCCC2)cc(c1)N1CC[NH2+]CC1	InChI=1S/C33H45FN4O3/c34-26-21-27(37-18-14-36-15-19-37)23-30(22-26)40-29-10-16-38(17-11-29)33(39)25-6-7-32(41-28-8-12-35-13-9-28)31(20-25)24-4-2-1-3-5-24/h6-7,20-24,28-29,35-36H,1-5,8-19H2/p+2	HNQIVJZMKJUQQB-UHFFFAOYSA-P	682662	US20240208940, Example 6	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			>100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682662	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682662&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055888	503272082							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425539	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(OC3CC[NH2+]CC3)c(c2)C2CCCCC2)cc(c1)N1CC[NH2+]CC1	InChI=1S/C33H45FN4O3/c34-26-21-27(37-18-14-36-15-19-37)23-30(22-26)40-29-10-16-38(17-11-29)33(39)25-6-7-32(41-28-8-12-35-13-9-28)31(20-25)24-4-2-1-3-5-24/h6-7,20-24,28-29,35-36H,1-5,8-19H2/p+2	HNQIVJZMKJUQQB-UHFFFAOYSA-P	682662	US20240208940, Example 6	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		>84000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682662	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682662&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055888	503272082							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425540	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H43FN4O3/c33-25-19-26(36-16-12-34-13-17-36)21-29(20-25)39-27-9-14-37(15-10-27)32(38)24-6-7-31(40-28-8-11-35-22-28)30(18-24)23-4-2-1-3-5-23/h6-7,18-21,23,27-28,34-35H,1-5,8-17,22H2/p+2	KERGUDBBTHPPMM-UHFFFAOYSA-P	682663	US20240208940, Example 7	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<70000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682663	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682663&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055889	503272083							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425541	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@@H]3CC[NH2+]C3)c(c2)C2CCCCC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H43FN4O3/c33-25-19-26(36-16-12-34-13-17-36)21-29(20-25)39-27-9-14-37(15-10-27)32(38)24-6-7-31(40-28-8-11-35-22-28)30(18-24)23-4-2-1-3-5-23/h6-7,18-21,23,27-28,34-35H,1-5,8-17,22H2/p+2	KERGUDBBTHPPMM-UHFFFAOYSA-P	682663	US20240208940, Example 7	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<60000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682663	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682663&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055889	503272083							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425542	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccccc2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H37FN4O3/c33-25-19-26(36-16-12-34-13-17-36)21-29(20-25)39-27-9-14-37(15-10-27)32(38)24-6-7-31(40-28-8-11-35-22-28)30(18-24)23-4-2-1-3-5-23/h1-7,18-21,27-28,34-35H,8-17,22H2/p+2	NAIUBKPGWAVAOY-UHFFFAOYSA-P	682664	US20240208940, Example 8	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<50000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682664	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682664&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055890	503272084							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425543	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccccc2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H37FN4O3/c33-25-19-26(36-16-12-34-13-17-36)21-29(20-25)39-27-9-14-37(15-10-27)32(38)24-6-7-31(40-28-8-11-35-22-28)30(18-24)23-4-2-1-3-5-23/h1-7,18-21,27-28,34-35H,8-17,22H2/p+2	NAIUBKPGWAVAOY-UHFFFAOYSA-P	682664	US20240208940, Example 8	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<50000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682664	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682664&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055890	503272084							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425544	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc(cc2)C(F)(F)F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C33H36F4N4O3/c34-25-18-26(40-15-11-38-12-16-40)20-29(19-25)43-27-8-13-41(14-9-27)32(42)23-3-6-31(44-28-7-10-39-21-28)30(17-23)22-1-4-24(5-2-22)33(35,36)37/h1-6,17-20,27-28,38-39H,7-16,21H2/p+2	BLPXJGDWAFKNNV-UHFFFAOYSA-P	682665	US20240208940, Example 9	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<20000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682665	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682665&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055891	503272085							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425545	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc(cc2)C(F)(F)F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C33H36F4N4O3/c34-25-18-26(40-15-11-38-12-16-40)20-29(19-25)43-27-8-13-41(14-9-27)32(42)23-3-6-31(44-28-7-10-39-21-28)30(17-23)22-1-4-24(5-2-22)33(35,36)37/h1-6,17-20,27-28,38-39H,7-16,21H2/p+2	BLPXJGDWAFKNNV-UHFFFAOYSA-P	682665	US20240208940, Example 9	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<20000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682665	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682665&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055891	503272085							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425546	CC(C)(C)c1ccc(cc1)-c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C36H45FN4O3/c1-36(2,3)27-7-4-25(5-8-27)33-20-26(6-9-34(33)44-31-10-13-39-24-31)35(42)41-16-11-30(12-17-41)43-32-22-28(37)21-29(23-32)40-18-14-38-15-19-40/h4-9,20-23,30-31,38-39H,10-19,24H2,1-3H3/p+2	ROKANYYIAWGDJI-UHFFFAOYSA-P	682666	US20240208940, Example 10	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<20000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682666	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682666&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055892	503272086							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425547	CC(C)(C)c1ccc(cc1)-c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C36H45FN4O3/c1-36(2,3)27-7-4-25(5-8-27)33-20-26(6-9-34(33)44-31-10-13-39-24-31)35(42)41-16-11-30(12-17-41)43-32-22-28(37)21-29(23-32)40-18-14-38-15-19-40/h4-9,20-23,30-31,38-39H,10-19,24H2,1-3H3/p+2	ROKANYYIAWGDJI-UHFFFAOYSA-P	682666	US20240208940, Example 10	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<20000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682666	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682666&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055892	503272086							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425548	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3ccsc3c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C34H37FN4O3S/c35-26-19-27(38-14-10-36-11-15-38)21-30(20-26)41-28-6-12-39(13-7-28)34(40)25-3-4-32(42-29-5-9-37-22-29)31(17-25)24-2-1-23-8-16-43-33(23)18-24/h1-4,8,16-21,28-29,36-37H,5-7,9-15,22H2/p+2	VUMQDFKHXXKWQW-UHFFFAOYSA-P	682667	US20240208940, Example 11	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<5000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682667	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682667&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055893	503272087							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425549	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3ccsc3c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C34H37FN4O3S/c35-26-19-27(38-14-10-36-11-15-38)21-30(20-26)41-28-6-12-39(13-7-28)34(40)25-3-4-32(42-29-5-9-37-22-29)31(17-25)24-2-1-23-8-16-43-33(23)18-24/h1-4,8,16-21,28-29,36-37H,5-7,9-15,22H2/p+2	VUMQDFKHXXKWQW-UHFFFAOYSA-P	682667	US20240208940, Example 11	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<5000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682667	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682667&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055893	503272087							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425550	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3ccccc3c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C36H39FN4O3/c37-29-21-30(40-17-13-38-14-18-40)23-33(22-29)43-31-10-15-41(16-11-31)36(42)28-7-8-35(44-32-9-12-39-24-32)34(20-28)27-6-5-25-3-1-2-4-26(25)19-27/h1-8,19-23,31-32,38-39H,9-18,24H2/p+2	XOYAJLOFRHFKQB-UHFFFAOYSA-P	682668	US20240208940, Example 12	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<5000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682668	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682668&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055894	503272088							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425551	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3ccccc3c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C36H39FN4O3/c37-29-21-30(40-17-13-38-14-18-40)23-33(22-29)43-31-10-15-41(16-11-31)36(42)28-7-8-35(44-32-9-12-39-24-32)34(20-28)27-6-5-25-3-1-2-4-26(25)19-27/h1-8,19-23,31-32,38-39H,9-18,24H2/p+2	XOYAJLOFRHFKQB-UHFFFAOYSA-P	682668	US20240208940, Example 12	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<5000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682668	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682668&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055894	503272088							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425552	Cn1cc(cn1)-c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C30H37FN6O3/c1-35-20-22(18-34-35)28-14-21(2-3-29(28)40-26-4-7-33-19-26)30(38)37-10-5-25(6-11-37)39-27-16-23(31)15-24(17-27)36-12-8-32-9-13-36/h2-3,14-18,20,25-26,32-33H,4-13,19H2,1H3/p+2	OUUPJPMXAADCLT-UHFFFAOYSA-P	682669	US20240208940, Example 13	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<10000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682669	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682669&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055895	503272089							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425553	Cn1cc(cn1)-c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C30H37FN6O3/c1-35-20-22(18-34-35)28-14-21(2-3-29(28)40-26-4-7-33-19-26)30(38)37-10-5-25(6-11-37)39-27-16-23(31)15-24(17-27)36-12-8-32-9-13-36/h2-3,14-18,20,25-26,32-33H,4-13,19H2,1H3/p+2	OUUPJPMXAADCLT-UHFFFAOYSA-P	682669	US20240208940, Example 13	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<10000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682669	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682669&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055895	503272089							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425554	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3[nH]ncc3c2)cc(c1)N1CC[NH2+]CC1	InChI=1S/C33H37FN6O3/c34-25-17-26(39-13-9-35-10-14-39)19-29(18-25)42-27-6-11-40(12-7-27)33(41)23-2-4-32(43-28-5-8-36-21-28)30(16-23)22-1-3-31-24(15-22)20-37-38-31/h1-4,15-20,27-28,35-36H,5-14,21H2,(H,37,38)/p+2	HACYBVJDWFZNMF-UHFFFAOYSA-P	682670	US20240208940, Example 14	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<10000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682670	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682670&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055896	503272090							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425555	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3[nH]ncc3c2)cc(c1)N1CC[NH2+]CC1	InChI=1S/C33H37FN6O3/c34-25-17-26(39-13-9-35-10-14-39)19-29(18-25)42-27-6-11-40(12-7-27)33(41)23-2-4-32(43-28-5-8-36-21-28)30(16-23)22-1-3-31-24(15-22)20-37-38-31/h1-4,15-20,27-28,35-36H,5-14,21H2,(H,37,38)/p+2	HACYBVJDWFZNMF-UHFFFAOYSA-P	682670	US20240208940, Example 14	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<10000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682670	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682670&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055896	503272090							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425556	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3cn[nH]c3c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C33H37FN6O3/c34-25-17-26(39-13-9-35-10-14-39)19-29(18-25)42-27-6-11-40(12-7-27)33(41)23-3-4-32(43-28-5-8-36-21-28)30(15-23)22-1-2-24-20-37-38-31(24)16-22/h1-4,15-20,27-28,35-36H,5-14,21H2,(H,37,38)/p+2	BGAHOBQJUFMFPH-UHFFFAOYSA-P	682671	US20240208940, Example 15	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<20000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682671	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682671&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055897	503272091							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425557	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3cn[nH]c3c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C33H37FN6O3/c34-25-17-26(39-13-9-35-10-14-39)19-29(18-25)42-27-6-11-40(12-7-27)33(41)23-3-4-32(43-28-5-8-36-21-28)30(15-23)22-1-2-24-20-37-38-31(24)16-22/h1-4,15-20,27-28,35-36H,5-14,21H2,(H,37,38)/p+2	BGAHOBQJUFMFPH-UHFFFAOYSA-P	682671	US20240208940, Example 15	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<20000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682671	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682671&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055897	503272091							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425558	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3nc[nH]c3c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C33H37FN6O3/c34-24-17-25(39-13-9-35-10-14-39)19-28(18-24)42-26-6-11-40(12-7-26)33(41)23-2-4-32(43-27-5-8-36-20-27)29(15-23)22-1-3-30-31(16-22)38-21-37-30/h1-4,15-19,21,26-27,35-36H,5-14,20H2,(H,37,38)/p+2	WOFPWVHXAVXHJG-UHFFFAOYSA-P	682672	US20240208940, Example 16	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<50000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682672	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682672&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055898	503272092							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425559	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2ccc3nc[nH]c3c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C33H37FN6O3/c34-24-17-25(39-13-9-35-10-14-39)19-28(18-24)42-26-6-11-40(12-7-26)33(41)23-2-4-32(43-27-5-8-36-20-27)29(15-23)22-1-3-30-31(16-22)38-21-37-30/h1-4,15-19,21,26-27,35-36H,5-14,20H2,(H,37,38)/p+2	WOFPWVHXAVXHJG-UHFFFAOYSA-P	682672	US20240208940, Example 16	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<50000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682672	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682672&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055898	503272092							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425560	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2cn[nH]c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C29H35FN6O3/c30-22-14-23(35-11-7-31-8-12-35)16-26(15-22)38-24-4-9-36(10-5-24)29(37)20-1-2-28(39-25-3-6-32-19-25)27(13-20)21-17-33-34-18-21/h1-2,13-18,24-25,31-32H,3-12,19H2,(H,33,34)/p+2	QDEHPOWLDQYBJC-UHFFFAOYSA-P	682673	US20240208940, Example 17	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<2000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682673	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682673&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055899	503272093							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425561	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)-c2cn[nH]c2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C29H35FN6O3/c30-22-14-23(35-11-7-31-8-12-35)16-26(15-22)38-24-4-9-36(10-5-24)29(37)20-1-2-28(39-25-3-6-32-19-25)27(13-20)21-17-33-34-18-21/h1-2,13-18,24-25,31-32H,3-12,19H2,(H,33,34)/p+2	QDEHPOWLDQYBJC-UHFFFAOYSA-P	682673	US20240208940, Example 17	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<2000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682673	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682673&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055899	503272093							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425562	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCC(CC2)C(F)(F)F)cc(c1)N1CC[NH2+]CC1 |r,w:25.27,28.34,wU:18.18,(8.21,-28.23,;6.87,-27.46,;6.87,-25.92,;5.54,-25.15,;5.54,-23.61,;4.21,-22.84,;2.87,-23.61,;1.54,-22.84,;1.54,-21.3,;2.87,-20.53,;4.21,-21.3,;.2,-20.53,;-1.13,-21.3,;.2,-18.99,;-1.13,-18.22,;-1.13,-16.68,;.2,-15.91,;.05,-14.52,;-1.13,-13.6,;-1.29,-12.06,;.17,-11.39,;1.2,-12.56,;.37,-13.96,;1.54,-16.68,;1.54,-18.22,;2.87,-15.91,;4.21,-16.68,;5.54,-15.91,;5.6,-14.29,;4.21,-13.6,;2.87,-14.37,;6.93,-13.5,;8.25,-12.71,;7.71,-14.82,;6.14,-12.18,;4.21,-25.92,;4.21,-27.46,;5.54,-28.23,;2.87,-28.23,;1.54,-27.46,;.16,-28.21,;.17,-29.78,;1.53,-30.58,;2.87,-29.77,)|	InChI=1S/C33H42F4N4O3/c34-25-18-26(40-15-11-38-12-16-40)20-29(19-25)43-27-8-13-41(14-9-27)32(42)23-3-6-31(44-28-7-10-39-21-28)30(17-23)22-1-4-24(5-2-22)33(35,36)37/h3,6,17-20,22,24,27-28,38-39H,1-2,4-5,7-16,21H2/p+2	XHNAKAIMMQAAQF-UHFFFAOYSA-P	682674	US20240208940, Example 18	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<20000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682674	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682674&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055900	503272094							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425563	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCC(CC2)C(F)(F)F)cc(c1)N1CC[NH2+]CC1 |r,w:25.27,28.34,wU:18.18,(8.21,-28.23,;6.87,-27.46,;6.87,-25.92,;5.54,-25.15,;5.54,-23.61,;4.21,-22.84,;2.87,-23.61,;1.54,-22.84,;1.54,-21.3,;2.87,-20.53,;4.21,-21.3,;.2,-20.53,;-1.13,-21.3,;.2,-18.99,;-1.13,-18.22,;-1.13,-16.68,;.2,-15.91,;.05,-14.52,;-1.13,-13.6,;-1.29,-12.06,;.17,-11.39,;1.2,-12.56,;.37,-13.96,;1.54,-16.68,;1.54,-18.22,;2.87,-15.91,;4.21,-16.68,;5.54,-15.91,;5.6,-14.29,;4.21,-13.6,;2.87,-14.37,;6.93,-13.5,;8.25,-12.71,;7.71,-14.82,;6.14,-12.18,;4.21,-25.92,;4.21,-27.46,;5.54,-28.23,;2.87,-28.23,;1.54,-27.46,;.16,-28.21,;.17,-29.78,;1.53,-30.58,;2.87,-29.77,)|	InChI=1S/C33H42F4N4O3/c34-25-18-26(40-15-11-38-12-16-40)20-29(19-25)43-27-8-13-41(14-9-27)32(42)23-3-6-31(44-28-7-10-39-21-28)30(17-23)22-1-4-24(5-2-22)33(35,36)37/h3,6,17-20,22,24,27-28,38-39H,1-2,4-5,7-16,21H2/p+2	XHNAKAIMMQAAQF-UHFFFAOYSA-P	682674	US20240208940, Example 18	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<20000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682674	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682674&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055900	503272094							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425564	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CCNCC1 |r,w:7.10,4.3,wD:17.18,(6.56,28.34,;5.23,29.11,;5.23,30.65,;6.56,29.88,;3.9,28.34,;3.9,26.8,;2.56,26.03,;1.23,26.8,;1.23,28.34,;2.56,29.11,;-.11,26.03,;-.11,24.49,;-1.44,23.72,;-2.77,24.49,;-2.77,26.03,;-1.44,26.8,;-1.44,28.34,;-2.77,29.11,;-2.93,30.64,;-4.5,31,;-5.27,29.64,;-4.17,28.44,;-1.44,22.18,;-2.77,21.41,;-.11,21.41,;-.11,19.87,;1.23,19.1,;2.56,19.87,;2.56,21.41,;1.23,22.18,;3.9,19.1,;3.9,17.56,;5.23,16.79,;5.23,15.25,;6.56,14.48,;3.9,14.48,;2.56,15.25,;2.56,16.79,;1.23,14.48,;-.11,15.25,;-1.48,14.49,;-1.47,12.92,;-.12,12.13,;1.23,12.94,)|	InChI=1S/C36H51FN4O3/c1-36(2,3)27-7-4-25(5-8-27)33-20-26(6-9-34(33)44-31-10-13-39-24-31)35(42)41-16-11-30(12-17-41)43-32-22-28(37)21-29(23-32)40-18-14-38-15-19-40/h6,9,20-23,25,27,30-31,38-39H,4-5,7-8,10-19,24H2,1-3H3/p+1	BWCHFLVXYSMPCQ-UHFFFAOYSA-O	682675	US20240208940, Example 19	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<5000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682675	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682675&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055901	503272095							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425565	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CCNCC1 |r,w:7.10,4.3,wD:17.18,(6.56,28.34,;5.23,29.11,;5.23,30.65,;6.56,29.88,;3.9,28.34,;3.9,26.8,;2.56,26.03,;1.23,26.8,;1.23,28.34,;2.56,29.11,;-.11,26.03,;-.11,24.49,;-1.44,23.72,;-2.77,24.49,;-2.77,26.03,;-1.44,26.8,;-1.44,28.34,;-2.77,29.11,;-2.93,30.64,;-4.5,31,;-5.27,29.64,;-4.17,28.44,;-1.44,22.18,;-2.77,21.41,;-.11,21.41,;-.11,19.87,;1.23,19.1,;2.56,19.87,;2.56,21.41,;1.23,22.18,;3.9,19.1,;3.9,17.56,;5.23,16.79,;5.23,15.25,;6.56,14.48,;3.9,14.48,;2.56,15.25,;2.56,16.79,;1.23,14.48,;-.11,15.25,;-1.48,14.49,;-1.47,12.92,;-.12,12.13,;1.23,12.94,)|	InChI=1S/C36H51FN4O3/c1-36(2,3)27-7-4-25(5-8-27)33-20-26(6-9-34(33)44-31-10-13-39-24-31)35(42)41-16-11-30(12-17-41)43-32-22-28(37)21-29(23-32)40-18-14-38-15-19-40/h6,9,20-23,25,27,30-31,38-39H,4-5,7-8,10-19,24H2,1-3H3/p+1	BWCHFLVXYSMPCQ-UHFFFAOYSA-O	682675	US20240208940, Example 19	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<5000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682675	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682675&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055901	503272095							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425566	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CCNC3)c(c2)C2CCOCC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C31H41FN4O4/c32-24-18-25(35-13-9-33-10-14-35)20-28(19-24)39-26-4-11-36(12-5-26)31(37)23-1-2-30(40-27-3-8-34-21-27)29(17-23)22-6-15-38-16-7-22/h1-2,17-20,22,26-27,33-34H,3-16,21H2/p+1	HHPPRVOYKFWVMP-UHFFFAOYSA-O	682676	US20240208940, Example 20	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			 100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682676	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682676&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055902	503272096							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425567	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CCNC3)c(c2)C2CCOCC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C31H41FN4O4/c32-24-18-25(35-13-9-33-10-14-35)20-28(19-24)39-26-4-11-36(12-5-26)31(37)23-1-2-30(40-27-3-8-34-21-27)29(17-23)22-6-15-38-16-7-22/h1-2,17-20,22,26-27,33-34H,3-16,21H2/p+1	HHPPRVOYKFWVMP-UHFFFAOYSA-O	682676	US20240208940, Example 20	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		 84000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682676	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682676&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055902	503272096							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425568	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCN(CC2)C(=O)C2CC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C35H46FN5O4/c36-27-20-28(39-17-11-37-12-18-39)22-31(21-27)44-29-8-15-41(16-9-29)35(43)26-3-4-33(45-30-5-10-38-23-30)32(19-26)24-6-13-40(14-7-24)34(42)25-1-2-25/h3-4,19-22,24-25,29-30,37-38H,1-2,5-18,23H2/p+2	IJYSMRIQFUMJLP-UHFFFAOYSA-P	682677	US20240208940, Example 21	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<50000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682677	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682677&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055903	503272097							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425569	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)C2CCN(CC2)C(=O)C2CC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C35H46FN5O4/c36-27-20-28(39-17-11-37-12-18-39)22-31(21-27)44-29-8-15-41(16-9-29)35(43)26-3-4-33(45-30-5-10-38-23-30)32(19-26)24-6-13-40(14-7-24)34(42)25-1-2-25/h3-4,19-22,24-25,29-30,37-38H,1-2,5-18,23H2/p+2	IJYSMRIQFUMJLP-UHFFFAOYSA-P	682677	US20240208940, Example 21	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<50000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682677	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682677&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055903	503272097							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425570	CC(C)C(=O)N1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C35H48FN5O4/c1-24(2)34(42)40-13-6-25(7-14-40)32-19-26(3-4-33(32)45-30-5-10-38-23-30)35(43)41-15-8-29(9-16-41)44-31-21-27(36)20-28(22-31)39-17-11-37-12-18-39/h3-4,19-22,24-25,29-30,37-38H,5-18,23H2,1-2H3/p+2	OWUYCYZHXAMZOW-UHFFFAOYSA-P	682678	US20240208940, Example 22	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<50000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682678	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682678&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055904	503272098							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425571	CC(C)C(=O)N1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C35H48FN5O4/c1-24(2)34(42)40-13-6-25(7-14-40)32-19-26(3-4-33(32)45-30-5-10-38-23-30)35(43)41-15-8-29(9-16-41)44-31-21-27(36)20-28(22-31)39-17-11-37-12-18-39/h3-4,19-22,24-25,29-30,37-38H,5-18,23H2,1-2H3/p+2	OWUYCYZHXAMZOW-UHFFFAOYSA-P	682678	US20240208940, Example 22	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<50000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682678	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682678&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055904	503272098							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425572	CC(O)C(=O)N1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r,w:1.1|	InChI=1S/C34H46FN5O5/c1-23(41)33(42)39-12-5-24(6-13-39)31-18-25(2-3-32(31)45-29-4-9-37-22-29)34(43)40-14-7-28(8-15-40)44-30-20-26(35)19-27(21-30)38-16-10-36-11-17-38/h2-3,18-21,23-24,28-29,36-37,41H,4-17,22H2,1H3/p+2	DGJBVLGGSOBXJL-UHFFFAOYSA-P	682679	US20240208940, Example 23	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<50000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682679	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682679&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055905	503272099							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425573	CC(O)C(=O)N1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r,w:1.1|	InChI=1S/C34H46FN5O5/c1-23(41)33(42)39-12-5-24(6-13-39)31-18-25(2-3-32(31)45-29-4-9-37-22-29)34(43)40-14-7-28(8-15-40)44-30-20-26(35)19-27(21-30)38-16-10-36-11-17-38/h2-3,18-21,23-24,28-29,36-37,41H,4-17,22H2,1H3/p+2	DGJBVLGGSOBXJL-UHFFFAOYSA-P	682679	US20240208940, Example 23	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<50000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682679	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682679&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055905	503272099							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425574	CC(C)(C)C(=O)N1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CCNCC1 |r|	InChI=1S/C36H50FN5O4/c1-36(2,3)35(44)42-14-7-25(8-15-42)32-20-26(4-5-33(32)46-30-6-11-39-24-30)34(43)41-16-9-29(10-17-41)45-31-22-27(37)21-28(23-31)40-18-12-38-13-19-40/h4-5,20-23,25,29-30,38-39H,6-19,24H2,1-3H3/p+1	ODEDFWVPEIZNQQ-UHFFFAOYSA-O	682680	US20240208940, Example 24	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			 100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682680	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682680&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055906	503272100							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425575	CC(C)(C)C(=O)N1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CCNCC1 |r|	InChI=1S/C36H50FN5O4/c1-36(2,3)35(44)42-14-7-25(8-15-42)32-20-26(4-5-33(32)46-30-6-11-39-24-30)34(43)41-16-9-29(10-17-41)45-31-22-27(37)21-28(23-31)40-18-12-38-13-19-40/h4-5,20-23,25,29-30,38-39H,6-19,24H2,1-3H3/p+1	ODEDFWVPEIZNQQ-UHFFFAOYSA-O	682680	US20240208940, Example 24	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		 84000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682680	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682680&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055906	503272100							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425576	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)N2CCCCC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C31H42FN5O3/c32-24-19-25(35-16-10-33-11-17-35)21-28(20-24)39-26-7-14-37(15-8-26)31(38)23-4-5-30(40-27-6-9-34-22-27)29(18-23)36-12-2-1-3-13-36/h4-5,18-21,26-27,33-34H,1-3,6-17,22H2/p+2	IXNJUANFKRAGTG-UHFFFAOYSA-P	682681	US20240208940, Example 25	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<60000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682681	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682681&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055907	503272101							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425577	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)N2CCCCC2)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C31H42FN5O3/c32-24-19-25(35-16-10-33-11-17-35)21-28(20-24)39-26-7-14-37(15-8-26)31(38)23-4-5-30(40-27-6-9-34-22-27)29(18-23)36-12-2-1-3-13-36/h4-5,18-21,26-27,33-34H,1-3,6-17,22H2/p+2	IXNJUANFKRAGTG-UHFFFAOYSA-P	682681	US20240208940, Example 25	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<60000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682681	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682681&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055907	503272101							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425578	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)N2CCC(CC2)C(F)(F)F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H41F4N5O3/c33-24-18-25(39-15-9-37-10-16-39)20-28(19-24)43-26-6-13-41(14-7-26)31(42)22-1-2-30(44-27-3-8-38-21-27)29(17-22)40-11-4-23(5-12-40)32(34,35)36/h1-2,17-20,23,26-27,37-38H,3-16,21H2/p+2	JIEBYTUYLPGUGF-UHFFFAOYSA-P	682682	US20240208940, Example 26	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682682	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682682&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055908	503272102							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425579	Fc1cc(OC2CCN(CC2)C(=O)c2ccc(O[C@H]3CC[NH2+]C3)c(c2)N2CCC(CC2)C(F)(F)F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H41F4N5O3/c33-24-18-25(39-15-9-37-10-16-39)20-28(19-24)43-26-6-13-41(14-7-26)31(42)22-1-2-30(44-27-3-8-38-21-27)29(17-22)40-11-4-23(5-12-40)32(34,35)36/h1-2,17-20,23,26-27,37-38H,3-16,21H2/p+2	JIEBYTUYLPGUGF-UHFFFAOYSA-P	682682	US20240208940, Example 26	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<100000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682682	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682682&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055908	503272102							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425580	CC(C)(C)C1CCN(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CCNCC1 |r|	InChI=1S/C35H50FN5O3/c1-35(2,3)26-7-14-40(15-8-26)32-20-25(4-5-33(32)44-30-6-11-38-24-30)34(42)41-16-9-29(10-17-41)43-31-22-27(36)21-28(23-31)39-18-12-37-13-19-39/h4-5,20-23,26,29-30,37-38H,6-19,24H2,1-3H3/p+1	JGNCOWYDOCPBPT-UHFFFAOYSA-O	682683	US20240208940, Example 27	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<30000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682683	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682683&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055909	503272103							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425581	CC(C)(C)C1CCN(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CCNCC1 |r|	InChI=1S/C35H50FN5O3/c1-35(2,3)26-7-14-40(15-8-26)32-20-25(4-5-33(32)44-30-6-11-38-24-30)34(42)41-16-9-29(10-17-41)43-31-22-27(36)21-28(23-31)39-18-12-37-13-19-39/h4-5,20-23,26,29-30,37-38H,6-19,24H2,1-3H3/p+1	JGNCOWYDOCPBPT-UHFFFAOYSA-O	682683	US20240208940, Example 27	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<30000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682683	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682683&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055909	503272103							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425582	CC1(O)CCN(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H44FN5O4/c1-32(40)7-14-37(15-8-32)29-18-23(2-3-30(29)42-27-4-9-35-22-27)31(39)38-12-5-26(6-13-38)41-28-20-24(33)19-25(21-28)36-16-10-34-11-17-36/h2-3,18-21,26-27,34-35,40H,4-17,22H2,1H3/p+2	YVZBZDXKHBGCQB-UHFFFAOYSA-P	682684	US20240208940, Example 28	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<20000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682684	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682684&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055910	503272104							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425583	CC1(O)CCN(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C32H44FN5O4/c1-32(40)7-14-37(15-8-32)29-18-23(2-3-30(29)42-27-4-9-35-22-27)31(39)38-12-5-26(6-13-38)41-28-20-24(33)19-25(21-28)36-16-10-34-11-17-36/h2-3,18-21,26-27,34-35,40H,4-17,22H2,1H3/p+2	YVZBZDXKHBGCQB-UHFFFAOYSA-P	682684	US20240208940, Example 28	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<20000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682684	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682684&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055910	503272104							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425584	CC(C)(O)C1CCN(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C34H48FN5O4/c1-34(2,42)25-6-13-39(14-7-25)31-19-24(3-4-32(31)44-29-5-10-37-23-29)33(41)40-15-8-28(9-16-40)43-30-21-26(35)20-27(22-30)38-17-11-36-12-18-38/h3-4,19-22,25,28-29,36-37,42H,5-18,23H2,1-2H3/p+2	VYXAWGBUUYUWFY-UHFFFAOYSA-P	682685	US20240208940, Example 29	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<50000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682685	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682685&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055912	503272105							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425585	CC(C)(O)C1CCN(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(F)cc(c1)N1CC[NH2+]CC1 |r|	InChI=1S/C34H48FN5O4/c1-34(2,42)25-6-13-39(14-7-25)31-19-24(3-4-32(31)44-29-5-10-37-23-29)33(41)40-15-8-28(9-16-40)43-30-21-26(35)20-27(22-30)38-17-11-36-12-18-38/h3-4,19-22,25,28-29,36-37,42H,5-18,23H2,1-2H3/p+2	VYXAWGBUUYUWFY-UHFFFAOYSA-P	682685	US20240208940, Example 29	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<50000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682685	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682685&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055912	503272105							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425586	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(Cl)cc(c1)N1CC[NH2+]CC1 |r,w:7.10,4.3,wU:17.18,(8.23,-14.37,;6.9,-13.6,;6.9,-12.06,;8.23,-12.83,;5.57,-14.37,;5.57,-15.91,;4.23,-16.68,;2.9,-15.91,;2.9,-14.37,;4.23,-13.6,;1.57,-16.68,;1.57,-18.22,;.23,-18.99,;-1.1,-18.22,;-1.1,-16.68,;.23,-15.91,;.08,-14.52,;-1.1,-13.6,;-1.26,-12.06,;.2,-11.39,;1.23,-12.56,;.4,-13.96,;.23,-20.53,;-1.1,-21.3,;1.57,-21.3,;1.57,-22.84,;2.9,-23.61,;4.23,-22.84,;4.23,-21.3,;2.9,-20.53,;5.57,-23.61,;5.57,-25.15,;6.9,-25.92,;6.9,-27.46,;8.23,-28.23,;5.57,-28.23,;4.23,-27.46,;4.23,-25.92,;2.9,-28.23,;1.57,-27.46,;.19,-28.21,;.2,-29.78,;1.56,-30.58,;2.9,-29.77,)|	InChI=1S/C36H51ClN4O3/c1-36(2,3)27-7-4-25(5-8-27)33-20-26(6-9-34(33)44-31-10-13-39-24-31)35(42)41-16-11-30(12-17-41)43-32-22-28(37)21-29(23-32)40-18-14-38-15-19-40/h6,9,20-23,25,27,30-31,38-39H,4-5,7-8,10-19,24H2,1-3H3/p+2	CISWHEKSBBPELK-UHFFFAOYSA-P	682686	US20240208940, Example 30	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<5000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682686	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682686&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055914	503272106							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425587	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(Cl)cc(c1)N1CC[NH2+]CC1 |r,w:7.10,4.3,wU:17.18,(8.23,-14.37,;6.9,-13.6,;6.9,-12.06,;8.23,-12.83,;5.57,-14.37,;5.57,-15.91,;4.23,-16.68,;2.9,-15.91,;2.9,-14.37,;4.23,-13.6,;1.57,-16.68,;1.57,-18.22,;.23,-18.99,;-1.1,-18.22,;-1.1,-16.68,;.23,-15.91,;.08,-14.52,;-1.1,-13.6,;-1.26,-12.06,;.2,-11.39,;1.23,-12.56,;.4,-13.96,;.23,-20.53,;-1.1,-21.3,;1.57,-21.3,;1.57,-22.84,;2.9,-23.61,;4.23,-22.84,;4.23,-21.3,;2.9,-20.53,;5.57,-23.61,;5.57,-25.15,;6.9,-25.92,;6.9,-27.46,;8.23,-28.23,;5.57,-28.23,;4.23,-27.46,;4.23,-25.92,;2.9,-28.23,;1.57,-27.46,;.19,-28.21,;.2,-29.78,;1.56,-30.58,;2.9,-29.77,)|	InChI=1S/C36H51ClN4O3/c1-36(2,3)27-7-4-25(5-8-27)33-20-26(6-9-34(33)44-31-10-13-39-24-31)35(42)41-16-11-30(12-17-41)43-32-22-28(37)21-29(23-32)40-18-14-38-15-19-40/h6,9,20-23,25,27,30-31,38-39H,4-5,7-8,10-19,24H2,1-3H3/p+2	CISWHEKSBBPELK-UHFFFAOYSA-P	682686	US20240208940, Example 30	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<5000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682686	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682686&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055914	503272106							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425588	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(cc(c1)C(F)(F)F)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(5.94,28.12,;4.61,28.89,;4.61,30.43,;5.94,29.66,;3.27,28.12,;3.27,26.58,;1.94,25.81,;.6,26.58,;.6,28.12,;1.94,28.89,;-.73,25.81,;-.73,24.27,;-2.06,23.5,;-3.4,24.27,;-3.4,25.81,;-2.06,26.58,;-2.06,28.12,;-3.4,28.89,;-3.56,30.43,;-5.13,30.78,;-5.89,29.42,;-4.79,28.23,;-2.06,21.96,;-3.4,21.19,;-.73,21.19,;-.73,19.65,;.6,18.88,;1.94,19.65,;1.94,21.19,;.6,21.96,;3.27,18.88,;3.27,17.34,;1.94,16.57,;1.94,15.03,;3.27,14.26,;4.65,15.01,;4.61,16.57,;5.99,14.24,;7.32,13.47,;6.76,15.57,;5.22,12.9,;.6,14.26,;-.73,15.03,;-2.1,14.28,;-2.09,12.71,;-.74,11.91,;.6,12.72,)|	InChI=1S/C37H51F3N4O3/c1-36(2,3)27-7-4-25(5-8-27)33-20-26(6-9-34(33)47-31-10-13-42-24-31)35(45)44-16-11-30(12-17-44)46-32-22-28(37(38,39)40)21-29(23-32)43-18-14-41-15-19-43/h6,9,20-23,25,27,30-31,41-42H,4-5,7-8,10-19,24H2,1-3H3/p+2	DDSUUGNIGXLDLH-UHFFFAOYSA-P	682687	US20240208940, Example 31	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<5000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682687	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682687&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055915	503272107							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425589	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(cc(c1)C(F)(F)F)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(5.94,28.12,;4.61,28.89,;4.61,30.43,;5.94,29.66,;3.27,28.12,;3.27,26.58,;1.94,25.81,;.6,26.58,;.6,28.12,;1.94,28.89,;-.73,25.81,;-.73,24.27,;-2.06,23.5,;-3.4,24.27,;-3.4,25.81,;-2.06,26.58,;-2.06,28.12,;-3.4,28.89,;-3.56,30.43,;-5.13,30.78,;-5.89,29.42,;-4.79,28.23,;-2.06,21.96,;-3.4,21.19,;-.73,21.19,;-.73,19.65,;.6,18.88,;1.94,19.65,;1.94,21.19,;.6,21.96,;3.27,18.88,;3.27,17.34,;1.94,16.57,;1.94,15.03,;3.27,14.26,;4.65,15.01,;4.61,16.57,;5.99,14.24,;7.32,13.47,;6.76,15.57,;5.22,12.9,;.6,14.26,;-.73,15.03,;-2.1,14.28,;-2.09,12.71,;-.74,11.91,;.6,12.72,)|	InChI=1S/C37H51F3N4O3/c1-36(2,3)27-7-4-25(5-8-27)33-20-26(6-9-34(33)47-31-10-13-42-24-31)35(45)44-16-11-30(12-17-44)46-32-22-28(37(38,39)40)21-29(23-32)43-18-14-41-15-19-43/h6,9,20-23,25,27,30-31,41-42H,4-5,7-8,10-19,24H2,1-3H3/p+2	DDSUUGNIGXLDLH-UHFFFAOYSA-P	682687	US20240208940, Example 31	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<5000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682687	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682687&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055915	503272107							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425590	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(cc(c1)N1CC[NH2+]CC1)C#N |r,w:7.10,4.3,wD:17.18,(6.67,6.74,;5.34,7.51,;5.34,9.05,;6.67,8.28,;4.01,6.74,;4.01,5.2,;2.67,4.43,;1.34,5.2,;1.34,6.74,;2.67,7.51,;.01,4.43,;.01,2.89,;-1.33,2.12,;-2.66,2.89,;-2.66,4.43,;-1.33,5.2,;-1.33,6.74,;-2.66,7.51,;-2.82,9.05,;-4.39,9.4,;-5.16,8.04,;-4.06,6.85,;-1.33,.58,;-2.66,-.19,;.01,-.19,;.01,-1.73,;1.34,-2.5,;2.67,-1.73,;2.67,-.19,;1.34,.58,;4.01,-2.5,;4.01,-4.04,;5.34,-4.81,;5.39,-6.37,;4.01,-7.12,;2.67,-6.35,;2.67,-4.81,;1.34,-7.12,;.01,-6.35,;-1.37,-7.1,;-1.36,-8.67,;-0,-9.47,;1.34,-8.66,;6.72,-7.14,;8.06,-7.91,)|	InChI=1S/C37H51N5O3/c1-37(2,3)29-7-4-27(5-8-29)34-22-28(6-9-35(34)45-32-10-13-40-25-32)36(43)42-16-11-31(12-17-42)44-33-21-26(24-38)20-30(23-33)41-18-14-39-15-19-41/h6,9,20-23,27,29,31-32,39-40H,4-5,7-8,10-19,25H2,1-3H3/p+2	UJEDVSMZJSIJRZ-UHFFFAOYSA-P	682688	US20240208940, Example 32	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<10000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682688	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682688&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055916	503272108							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425591	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(cc(c1)N1CC[NH2+]CC1)C#N |r,w:7.10,4.3,wD:17.18,(6.67,6.74,;5.34,7.51,;5.34,9.05,;6.67,8.28,;4.01,6.74,;4.01,5.2,;2.67,4.43,;1.34,5.2,;1.34,6.74,;2.67,7.51,;.01,4.43,;.01,2.89,;-1.33,2.12,;-2.66,2.89,;-2.66,4.43,;-1.33,5.2,;-1.33,6.74,;-2.66,7.51,;-2.82,9.05,;-4.39,9.4,;-5.16,8.04,;-4.06,6.85,;-1.33,.58,;-2.66,-.19,;.01,-.19,;.01,-1.73,;1.34,-2.5,;2.67,-1.73,;2.67,-.19,;1.34,.58,;4.01,-2.5,;4.01,-4.04,;5.34,-4.81,;5.39,-6.37,;4.01,-7.12,;2.67,-6.35,;2.67,-4.81,;1.34,-7.12,;.01,-6.35,;-1.37,-7.1,;-1.36,-8.67,;-0,-9.47,;1.34,-8.66,;6.72,-7.14,;8.06,-7.91,)|	InChI=1S/C37H51N5O3/c1-37(2,3)29-7-4-27(5-8-29)34-22-28(6-9-35(34)45-32-10-13-40-25-32)36(43)42-16-11-31(12-17-42)44-33-21-26(24-38)20-30(23-33)41-18-14-39-15-19-41/h6,9,20-23,27,29,31-32,39-40H,4-5,7-8,10-19,25H2,1-3H3/p+2	UJEDVSMZJSIJRZ-UHFFFAOYSA-P	682688	US20240208940, Example 32	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<10000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682688	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682688&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055916	503272108							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425592	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1F)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(7.83,-14.1,;6.5,-13.33,;6.5,-11.79,;7.83,-12.56,;5.16,-14.1,;5.16,-15.64,;3.83,-16.41,;2.5,-15.64,;2.5,-14.1,;3.83,-13.33,;1.16,-16.41,;1.16,-17.95,;-.17,-18.72,;-1.5,-17.95,;-1.5,-16.41,;-.17,-15.64,;-.17,-14.1,;-1.5,-13.33,;-1.66,-11.8,;-3.23,-11.44,;-4,-12.8,;-2.9,-13.99,;-.17,-20.26,;-1.5,-21.03,;1.16,-21.03,;1.16,-22.57,;2.5,-23.34,;3.83,-22.57,;3.83,-21.03,;2.5,-20.26,;5.16,-23.34,;5.16,-24.88,;3.83,-25.65,;3.83,-27.19,;5.16,-27.96,;6.5,-27.19,;6.5,-25.65,;7.83,-24.88,;2.5,-27.96,;1.16,-27.19,;-.21,-27.95,;-.2,-29.52,;1.15,-30.31,;2.5,-29.5,)|	InChI=1S/C36H51FN4O3/c1-36(2,3)27-7-4-25(5-8-27)31-22-26(6-11-33(31)44-30-12-15-39-24-30)35(42)41-18-13-29(14-19-41)43-34-23-28(9-10-32(34)37)40-20-16-38-17-21-40/h6,9-11,22-23,25,27,29-30,38-39H,4-5,7-8,12-21,24H2,1-3H3/p+2	OBWSSAISDUSOFF-UHFFFAOYSA-P	682689	US20240208940, Example 33	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<10000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682689	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682689&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055917	503272109							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425593	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1F)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(7.83,-14.1,;6.5,-13.33,;6.5,-11.79,;7.83,-12.56,;5.16,-14.1,;5.16,-15.64,;3.83,-16.41,;2.5,-15.64,;2.5,-14.1,;3.83,-13.33,;1.16,-16.41,;1.16,-17.95,;-.17,-18.72,;-1.5,-17.95,;-1.5,-16.41,;-.17,-15.64,;-.17,-14.1,;-1.5,-13.33,;-1.66,-11.8,;-3.23,-11.44,;-4,-12.8,;-2.9,-13.99,;-.17,-20.26,;-1.5,-21.03,;1.16,-21.03,;1.16,-22.57,;2.5,-23.34,;3.83,-22.57,;3.83,-21.03,;2.5,-20.26,;5.16,-23.34,;5.16,-24.88,;3.83,-25.65,;3.83,-27.19,;5.16,-27.96,;6.5,-27.19,;6.5,-25.65,;7.83,-24.88,;2.5,-27.96,;1.16,-27.19,;-.21,-27.95,;-.2,-29.52,;1.15,-30.31,;2.5,-29.5,)|	InChI=1S/C36H51FN4O3/c1-36(2,3)27-7-4-25(5-8-27)31-22-26(6-11-33(31)44-30-12-15-39-24-30)35(42)41-18-13-29(14-19-41)43-34-23-28(9-10-32(34)37)40-20-16-38-17-21-40/h6,9-11,22-23,25,27,29-30,38-39H,4-5,7-8,12-21,24H2,1-3H3/p+2	OBWSSAISDUSOFF-UHFFFAOYSA-P	682689	US20240208940, Example 33	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<10000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682689	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682689&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055917	503272109							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425594	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1ccc(F)c(c1)N1CC[NH2+]CC1 |r,w:7.10,4.3,wU:17.18,(6.74,28.3,;5.41,29.07,;5.41,30.61,;6.74,29.84,;4.07,28.3,;4.07,26.76,;2.74,25.99,;1.4,26.76,;1.4,28.3,;2.74,29.07,;.07,25.99,;.07,24.45,;-1.26,23.68,;-2.6,24.45,;-2.6,25.99,;-1.26,26.76,;-1.42,28.15,;-2.6,29.07,;-2.76,30.61,;-1.3,31.28,;-.27,30.11,;-1.09,28.71,;-1.26,22.14,;-2.6,21.37,;.07,21.37,;.07,19.83,;1.4,19.06,;2.74,19.83,;2.74,21.37,;1.4,22.14,;4.07,19.06,;4.07,17.52,;5.41,16.75,;5.41,15.21,;4.07,14.44,;4.07,12.9,;2.74,15.21,;2.74,16.75,;1.4,14.44,;.07,15.21,;-1.3,14.46,;-1.29,12.89,;.06,12.09,;1.4,12.9,)|	InChI=1S/C36H51FN4O3/c1-36(2,3)27-7-4-25(5-8-27)31-22-26(6-11-34(31)44-30-12-15-39-24-30)35(42)41-18-13-28(14-19-41)43-29-9-10-32(37)33(23-29)40-20-16-38-17-21-40/h6,9-11,22-23,25,27-28,30,38-39H,4-5,7-8,12-21,24H2,1-3H3/p+2	OIFLGXRSAAMBIZ-UHFFFAOYSA-P	682690	US20240208940, Example 34	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<10000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682690	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682690&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055918	503272110							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425595	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1ccc(F)c(c1)N1CC[NH2+]CC1 |r,w:7.10,4.3,wU:17.18,(6.74,28.3,;5.41,29.07,;5.41,30.61,;6.74,29.84,;4.07,28.3,;4.07,26.76,;2.74,25.99,;1.4,26.76,;1.4,28.3,;2.74,29.07,;.07,25.99,;.07,24.45,;-1.26,23.68,;-2.6,24.45,;-2.6,25.99,;-1.26,26.76,;-1.42,28.15,;-2.6,29.07,;-2.76,30.61,;-1.3,31.28,;-.27,30.11,;-1.09,28.71,;-1.26,22.14,;-2.6,21.37,;.07,21.37,;.07,19.83,;1.4,19.06,;2.74,19.83,;2.74,21.37,;1.4,22.14,;4.07,19.06,;4.07,17.52,;5.41,16.75,;5.41,15.21,;4.07,14.44,;4.07,12.9,;2.74,15.21,;2.74,16.75,;1.4,14.44,;.07,15.21,;-1.3,14.46,;-1.29,12.89,;.06,12.09,;1.4,12.9,)|	InChI=1S/C36H51FN4O3/c1-36(2,3)27-7-4-25(5-8-27)31-22-26(6-11-34(31)44-30-12-15-39-24-30)35(42)41-18-13-28(14-19-41)43-29-9-10-32(37)33(23-29)40-20-16-38-17-21-40/h6,9-11,22-23,25,27-28,30,38-39H,4-5,7-8,12-21,24H2,1-3H3/p+2	OIFLGXRSAAMBIZ-UHFFFAOYSA-P	682690	US20240208940, Example 34	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<10000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682690	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682690&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055918	503272110							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425596	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(cc(F)c1F)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(7.31,7.21,;5.98,7.98,;5.98,9.52,;7.31,8.75,;4.65,7.21,;4.65,5.67,;3.31,4.9,;1.98,5.67,;1.98,7.21,;3.31,7.98,;.64,4.9,;.64,3.36,;-.69,2.59,;-2.02,3.36,;-2.02,4.9,;-.69,5.67,;-.69,7.21,;-2.02,7.98,;-2.18,9.51,;-3.75,9.87,;-4.52,8.51,;-3.42,7.32,;-.69,1.05,;-2.02,.28,;.64,.28,;.64,-1.26,;1.98,-2.03,;3.31,-1.26,;3.31,.28,;1.98,1.05,;4.65,-2.03,;4.65,-3.57,;3.31,-4.34,;3.31,-5.88,;4.65,-6.65,;5.98,-5.88,;7.31,-6.65,;5.98,-4.34,;7.31,-3.57,;1.98,-6.65,;.64,-5.88,;-.73,-6.64,;-.72,-8.2,;.63,-9,;1.98,-8.19,)|	InChI=1S/C36H50F2N4O3/c1-36(2,3)26-7-4-24(5-8-26)30-20-25(6-9-32(30)45-29-10-13-40-23-29)35(43)42-16-11-28(12-17-42)44-33-22-27(21-31(37)34(33)38)41-18-14-39-15-19-41/h6,9,20-22,24,26,28-29,39-40H,4-5,7-8,10-19,23H2,1-3H3/p+2	LOLOKCTZQPBHKI-UHFFFAOYSA-P	682691	US20240208940, Example 35	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<5000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682691	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682691&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055919	503272111							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425597	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(cc(F)c1F)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(7.31,7.21,;5.98,7.98,;5.98,9.52,;7.31,8.75,;4.65,7.21,;4.65,5.67,;3.31,4.9,;1.98,5.67,;1.98,7.21,;3.31,7.98,;.64,4.9,;.64,3.36,;-.69,2.59,;-2.02,3.36,;-2.02,4.9,;-.69,5.67,;-.69,7.21,;-2.02,7.98,;-2.18,9.51,;-3.75,9.87,;-4.52,8.51,;-3.42,7.32,;-.69,1.05,;-2.02,.28,;.64,.28,;.64,-1.26,;1.98,-2.03,;3.31,-1.26,;3.31,.28,;1.98,1.05,;4.65,-2.03,;4.65,-3.57,;3.31,-4.34,;3.31,-5.88,;4.65,-6.65,;5.98,-5.88,;7.31,-6.65,;5.98,-4.34,;7.31,-3.57,;1.98,-6.65,;.64,-5.88,;-.73,-6.64,;-.72,-8.2,;.63,-9,;1.98,-8.19,)|	InChI=1S/C36H50F2N4O3/c1-36(2,3)26-7-4-24(5-8-26)30-20-25(6-9-32(30)45-29-10-13-40-23-29)35(43)42-16-11-28(12-17-42)44-33-22-27(21-31(37)34(33)38)41-18-14-39-15-19-41/h6,9,20-22,24,26,28-29,39-40H,4-5,7-8,10-19,23H2,1-3H3/p+2	LOLOKCTZQPBHKI-UHFFFAOYSA-P	682691	US20240208940, Example 35	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<5000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682691	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682691&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055919	503272111							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425598	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1Cl)N1CC[NH2+]CC1 |r,w:7.10,4.3,wU:17.18,(8.11,-14.28,;6.77,-13.51,;6.77,-11.97,;8.11,-12.74,;5.44,-14.28,;5.44,-15.82,;4.11,-16.59,;2.77,-15.82,;2.77,-14.28,;4.11,-13.51,;1.44,-16.59,;1.44,-18.13,;.11,-18.9,;-1.23,-18.13,;-1.23,-16.59,;.11,-15.82,;-.05,-14.43,;-1.23,-13.51,;-1.39,-11.97,;.07,-11.3,;1.1,-12.47,;.28,-13.87,;.11,-20.44,;-1.23,-21.21,;1.44,-21.21,;1.44,-22.75,;2.77,-23.52,;4.11,-22.75,;4.11,-21.21,;2.77,-20.44,;5.44,-23.52,;5.44,-25.06,;4.11,-25.83,;4.11,-27.37,;5.44,-28.14,;6.77,-27.37,;6.77,-25.83,;8.11,-25.06,;2.77,-28.14,;1.44,-27.37,;.06,-28.12,;.07,-29.69,;1.43,-30.49,;2.77,-29.68,)|	InChI=1S/C36H51ClN4O3/c1-36(2,3)27-7-4-25(5-8-27)31-22-26(6-11-33(31)44-30-12-15-39-24-30)35(42)41-18-13-29(14-19-41)43-34-23-28(9-10-32(34)37)40-20-16-38-17-21-40/h6,9-11,22-23,25,27,29-30,38-39H,4-5,7-8,12-21,24H2,1-3H3/p+2	JEYJIBOQPICDLI-UHFFFAOYSA-P	682692	US20240208940, Example 36	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<5000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682692	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682692&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055920	503272112							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425599	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1Cl)N1CC[NH2+]CC1 |r,w:7.10,4.3,wU:17.18,(8.11,-14.28,;6.77,-13.51,;6.77,-11.97,;8.11,-12.74,;5.44,-14.28,;5.44,-15.82,;4.11,-16.59,;2.77,-15.82,;2.77,-14.28,;4.11,-13.51,;1.44,-16.59,;1.44,-18.13,;.11,-18.9,;-1.23,-18.13,;-1.23,-16.59,;.11,-15.82,;-.05,-14.43,;-1.23,-13.51,;-1.39,-11.97,;.07,-11.3,;1.1,-12.47,;.28,-13.87,;.11,-20.44,;-1.23,-21.21,;1.44,-21.21,;1.44,-22.75,;2.77,-23.52,;4.11,-22.75,;4.11,-21.21,;2.77,-20.44,;5.44,-23.52,;5.44,-25.06,;4.11,-25.83,;4.11,-27.37,;5.44,-28.14,;6.77,-27.37,;6.77,-25.83,;8.11,-25.06,;2.77,-28.14,;1.44,-27.37,;.06,-28.12,;.07,-29.69,;1.43,-30.49,;2.77,-29.68,)|	InChI=1S/C36H51ClN4O3/c1-36(2,3)27-7-4-25(5-8-27)31-22-26(6-11-33(31)44-30-12-15-39-24-30)35(42)41-18-13-29(14-19-41)43-34-23-28(9-10-32(34)37)40-20-16-38-17-21-40/h6,9-11,22-23,25,27,29-30,38-39H,4-5,7-8,12-21,24H2,1-3H3/p+2	JEYJIBOQPICDLI-UHFFFAOYSA-P	682692	US20240208940, Example 36	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<5000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682692	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682692&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055920	503272112							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425600	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C#N)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(6.14,28.45,;4.81,29.22,;4.81,30.76,;6.14,29.99,;3.47,28.45,;3.47,26.91,;2.14,26.14,;.81,26.91,;.81,28.45,;2.14,29.22,;-.53,26.14,;-.53,24.6,;-1.86,23.83,;-3.19,24.6,;-3.19,26.14,;-1.86,26.91,;-1.86,28.45,;-3.19,29.22,;-3.35,30.75,;-4.92,31.11,;-5.69,29.74,;-4.59,28.55,;-1.86,22.29,;-3.19,21.52,;-.53,21.52,;-.53,19.98,;.81,19.21,;2.14,19.98,;2.14,21.52,;.81,22.29,;3.47,19.21,;3.47,17.67,;2.14,16.9,;2.14,15.36,;3.47,14.59,;4.81,15.36,;4.86,16.93,;6.19,17.7,;7.52,18.47,;.81,14.59,;-.53,15.36,;-1.9,14.6,;-1.89,13.03,;-.54,12.24,;.81,13.05,)|	InChI=1S/C37H51N5O3/c1-37(2,3)29-8-4-26(5-9-29)33-22-27(7-11-34(33)45-32-12-15-40-25-32)36(43)42-18-13-31(14-19-42)44-35-23-30(10-6-28(35)24-38)41-20-16-39-17-21-41/h6-7,10-11,22-23,26,29,31-32,39-40H,4-5,8-9,12-21,25H2,1-3H3/p+2	QQTSKTWBOQEFNY-UHFFFAOYSA-P	682693	US20240208940, Example 37	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<2000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682693	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682693&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055921	503272113							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425601	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C#N)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(6.14,28.45,;4.81,29.22,;4.81,30.76,;6.14,29.99,;3.47,28.45,;3.47,26.91,;2.14,26.14,;.81,26.91,;.81,28.45,;2.14,29.22,;-.53,26.14,;-.53,24.6,;-1.86,23.83,;-3.19,24.6,;-3.19,26.14,;-1.86,26.91,;-1.86,28.45,;-3.19,29.22,;-3.35,30.75,;-4.92,31.11,;-5.69,29.74,;-4.59,28.55,;-1.86,22.29,;-3.19,21.52,;-.53,21.52,;-.53,19.98,;.81,19.21,;2.14,19.98,;2.14,21.52,;.81,22.29,;3.47,19.21,;3.47,17.67,;2.14,16.9,;2.14,15.36,;3.47,14.59,;4.81,15.36,;4.86,16.93,;6.19,17.7,;7.52,18.47,;.81,14.59,;-.53,15.36,;-1.9,14.6,;-1.89,13.03,;-.54,12.24,;.81,13.05,)|	InChI=1S/C37H51N5O3/c1-37(2,3)29-8-4-26(5-9-29)33-22-27(7-11-34(33)45-32-12-15-40-25-32)36(43)42-18-13-31(14-19-42)44-35-23-30(10-6-28(35)24-38)41-20-16-39-17-21-41/h6-7,10-11,22-23,26,29,31-32,39-40H,4-5,8-9,12-21,25H2,1-3H3/p+2	QQTSKTWBOQEFNY-UHFFFAOYSA-P	682693	US20240208940, Example 37	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<2000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682693	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682693&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055921	503272113							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425602	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cccc(c1)N1CC[NH2+]CC1 |r,w:7.10,4.3,wU:17.18,(6.49,6.4,;5.16,7.17,;5.16,8.71,;6.49,7.94,;3.82,6.4,;3.82,4.86,;2.49,4.09,;1.16,4.86,;1.16,6.4,;2.49,7.17,;-.18,4.09,;-.18,2.55,;-1.51,1.78,;-2.84,2.55,;-2.84,4.09,;-1.51,4.86,;-1.66,6.24,;-2.84,7.17,;-3.01,8.7,;-1.55,9.37,;-.51,8.2,;-1.34,6.8,;-1.51,.24,;-2.84,-.53,;-.18,-.53,;-.18,-2.07,;1.16,-2.84,;2.49,-2.07,;2.49,-.53,;1.16,.24,;3.82,-2.84,;3.82,-4.38,;5.16,-5.15,;5.16,-6.69,;3.82,-7.46,;2.49,-6.69,;2.49,-5.15,;1.16,-7.46,;-.18,-6.69,;-1.55,-7.45,;-1.54,-9.02,;-.19,-9.82,;1.16,-9,)|	InChI=1S/C36H52N4O3/c1-36(2,3)28-10-7-26(8-11-28)33-23-27(9-12-34(33)43-32-13-16-38-25-32)35(41)40-19-14-30(15-20-40)42-31-6-4-5-29(24-31)39-21-17-37-18-22-39/h4-6,9,12,23-24,26,28,30,32,37-38H,7-8,10-11,13-22,25H2,1-3H3/p+2	GIAHGWKZSGBHQT-UHFFFAOYSA-P	682694	US20240208940, Example 38	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<20000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682694	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682694&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055922	503272114							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425603	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cccc(c1)N1CC[NH2+]CC1 |r,w:7.10,4.3,wU:17.18,(6.49,6.4,;5.16,7.17,;5.16,8.71,;6.49,7.94,;3.82,6.4,;3.82,4.86,;2.49,4.09,;1.16,4.86,;1.16,6.4,;2.49,7.17,;-.18,4.09,;-.18,2.55,;-1.51,1.78,;-2.84,2.55,;-2.84,4.09,;-1.51,4.86,;-1.66,6.24,;-2.84,7.17,;-3.01,8.7,;-1.55,9.37,;-.51,8.2,;-1.34,6.8,;-1.51,.24,;-2.84,-.53,;-.18,-.53,;-.18,-2.07,;1.16,-2.84,;2.49,-2.07,;2.49,-.53,;1.16,.24,;3.82,-2.84,;3.82,-4.38,;5.16,-5.15,;5.16,-6.69,;3.82,-7.46,;2.49,-6.69,;2.49,-5.15,;1.16,-7.46,;-.18,-6.69,;-1.55,-7.45,;-1.54,-9.02,;-.19,-9.82,;1.16,-9,)|	InChI=1S/C36H52N4O3/c1-36(2,3)28-10-7-26(8-11-28)33-23-27(9-12-34(33)43-32-13-16-38-25-32)35(41)40-19-14-30(15-20-40)42-31-6-4-5-29(24-31)39-21-17-37-18-22-39/h4-6,9,12,23-24,26,28,30,32,37-38H,7-8,10-11,13-22,25H2,1-3H3/p+2	GIAHGWKZSGBHQT-UHFFFAOYSA-P	682694	US20240208940, Example 38	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<20000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682694	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682694&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055922	503272114							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425604	COC(=O)c1ccc(cc1OC1CCN(CC1)C(=O)c1ccc(O[C@H]2CC[NH2+]C2)c(c1)C1CCC(CC1)C(C)(C)C)N1CC[NH2+]CC1 |r,w:31.34,34.41,wU:24.25,(8.25,-27.48,;8.25,-25.94,;6.92,-25.17,;6.92,-23.63,;5.59,-25.94,;5.54,-27.51,;4.21,-28.28,;2.87,-27.51,;2.87,-25.97,;4.21,-25.2,;4.21,-23.66,;2.87,-22.89,;1.54,-23.66,;.2,-22.89,;.2,-21.35,;1.54,-20.58,;2.87,-21.35,;-1.13,-20.58,;-2.46,-21.35,;-1.13,-19.04,;-2.46,-18.27,;-2.46,-16.73,;-1.13,-15.96,;-1.28,-14.57,;-2.46,-13.65,;-2.62,-12.12,;-1.16,-11.44,;-.13,-12.62,;-.96,-14.01,;.2,-16.73,;.2,-18.27,;1.54,-15.96,;2.87,-16.73,;4.21,-15.96,;4.21,-14.42,;2.87,-13.65,;1.54,-14.42,;5.54,-13.65,;6.87,-14.42,;5.54,-12.11,;6.87,-12.88,;1.54,-28.28,;.2,-27.51,;-1.17,-28.27,;-1.16,-29.84,;.19,-30.63,;1.54,-29.82,)|	InChI=1S/C38H54N4O5/c1-38(2,3)28-8-5-26(6-9-28)33-23-27(7-12-34(33)47-31-13-16-40-25-31)36(43)42-19-14-30(15-20-42)46-35-24-29(41-21-17-39-18-22-41)10-11-32(35)37(44)45-4/h7,10-12,23-24,26,28,30-31,39-40H,5-6,8-9,13-22,25H2,1-4H3/p+2	VIYASZPPPWIMRD-UHFFFAOYSA-P	682695	US20240208940, Example 39	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			 17000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682695	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682695&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055923	503272115							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425605	COC(=O)c1ccc(cc1OC1CCN(CC1)C(=O)c1ccc(O[C@H]2CC[NH2+]C2)c(c1)C1CCC(CC1)C(C)(C)C)N1CC[NH2+]CC1 |r,w:31.34,34.41,wU:24.25,(8.25,-27.48,;8.25,-25.94,;6.92,-25.17,;6.92,-23.63,;5.59,-25.94,;5.54,-27.51,;4.21,-28.28,;2.87,-27.51,;2.87,-25.97,;4.21,-25.2,;4.21,-23.66,;2.87,-22.89,;1.54,-23.66,;.2,-22.89,;.2,-21.35,;1.54,-20.58,;2.87,-21.35,;-1.13,-20.58,;-2.46,-21.35,;-1.13,-19.04,;-2.46,-18.27,;-2.46,-16.73,;-1.13,-15.96,;-1.28,-14.57,;-2.46,-13.65,;-2.62,-12.12,;-1.16,-11.44,;-.13,-12.62,;-.96,-14.01,;.2,-16.73,;.2,-18.27,;1.54,-15.96,;2.87,-16.73,;4.21,-15.96,;4.21,-14.42,;2.87,-13.65,;1.54,-14.42,;5.54,-13.65,;6.87,-14.42,;5.54,-12.11,;6.87,-12.88,;1.54,-28.28,;.2,-27.51,;-1.17,-28.27,;-1.16,-29.84,;.19,-30.63,;1.54,-29.82,)|	InChI=1S/C38H54N4O5/c1-38(2,3)28-8-5-26(6-9-28)33-23-27(7-12-34(33)47-31-13-16-40-25-31)36(43)42-19-14-30(15-20-42)46-35-24-29(41-21-17-39-18-22-41)10-11-32(35)37(44)45-4/h7,10-12,23-24,26,28,30-31,39-40H,5-6,8-9,13-22,25H2,1-4H3/p+2	VIYASZPPPWIMRD-UHFFFAOYSA-P	682695	US20240208940, Example 39	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		 14000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682695	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682695&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055923	503272115							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425606	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C(O)=O)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(5.9,28.38,;4.57,29.15,;4.57,30.69,;5.9,29.92,;3.23,28.38,;3.23,26.84,;1.9,26.07,;.56,26.84,;.56,28.38,;1.9,29.15,;-.77,26.07,;-.77,24.53,;-2.1,23.76,;-3.44,24.53,;-3.44,26.07,;-2.1,26.84,;-2.1,28.38,;-3.44,29.15,;-3.6,30.68,;-5.17,31.04,;-5.93,29.67,;-4.83,28.48,;-2.1,22.22,;-3.44,21.45,;-.77,21.45,;-.77,19.91,;.56,19.14,;1.9,19.91,;1.9,21.45,;.56,22.22,;3.23,19.14,;3.23,17.6,;1.9,16.83,;1.9,15.29,;3.23,14.52,;4.57,15.29,;4.61,16.85,;5.95,17.62,;5.95,19.16,;7.28,16.85,;.56,14.52,;-.77,15.29,;-2.14,14.53,;-2.13,12.96,;-.78,12.17,;.56,12.98,)|	InChI=1S/C37H52N4O5/c1-37(2,3)27-7-4-25(5-8-27)32-22-26(6-11-33(32)46-30-12-15-39-24-30)35(42)41-18-13-29(14-19-41)45-34-23-28(9-10-31(34)36(43)44)40-20-16-38-17-21-40/h6,9-11,22-23,25,27,29-30,38-39H,4-5,7-8,12-21,24H2,1-3H3,(H,43,44)/p+2	JJVOIXUVDMVTFG-UHFFFAOYSA-P	682696	US20240208940, Example 40	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			 100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682696	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682696&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055924	503272116							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425607	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C(O)=O)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(5.9,28.38,;4.57,29.15,;4.57,30.69,;5.9,29.92,;3.23,28.38,;3.23,26.84,;1.9,26.07,;.56,26.84,;.56,28.38,;1.9,29.15,;-.77,26.07,;-.77,24.53,;-2.1,23.76,;-3.44,24.53,;-3.44,26.07,;-2.1,26.84,;-2.1,28.38,;-3.44,29.15,;-3.6,30.68,;-5.17,31.04,;-5.93,29.67,;-4.83,28.48,;-2.1,22.22,;-3.44,21.45,;-.77,21.45,;-.77,19.91,;.56,19.14,;1.9,19.91,;1.9,21.45,;.56,22.22,;3.23,19.14,;3.23,17.6,;1.9,16.83,;1.9,15.29,;3.23,14.52,;4.57,15.29,;4.61,16.85,;5.95,17.62,;5.95,19.16,;7.28,16.85,;.56,14.52,;-.77,15.29,;-2.14,14.53,;-2.13,12.96,;-.78,12.17,;.56,12.98,)|	InChI=1S/C37H52N4O5/c1-37(2,3)27-7-4-25(5-8-27)32-22-26(6-11-33(32)46-30-12-15-39-24-30)35(42)41-18-13-29(14-19-41)45-34-23-28(9-10-31(34)36(43)44)40-20-16-38-17-21-40/h6,9-11,22-23,25,27,29-30,38-39H,4-5,7-8,12-21,24H2,1-3H3,(H,43,44)/p+2	JJVOIXUVDMVTFG-UHFFFAOYSA-P	682696	US20240208940, Example 40	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		 84000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682696	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682696&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055924	503272116							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425608	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C(N)=O)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(6.44,7,;5.11,7.77,;5.11,9.31,;6.44,8.54,;3.77,7,;3.77,5.46,;2.44,4.69,;1.1,5.46,;1.1,7,;2.44,7.77,;-.23,4.69,;-.23,3.15,;-1.56,2.38,;-2.9,3.15,;-2.9,4.69,;-1.56,5.46,;-1.56,7,;-2.9,7.77,;-3.06,9.3,;-4.62,9.66,;-5.39,8.29,;-4.29,7.1,;-1.56,.84,;-2.9,.07,;-.23,.07,;-.23,-1.47,;1.1,-2.24,;2.44,-1.47,;2.44,.07,;1.1,.84,;3.77,-2.24,;3.77,-3.78,;2.44,-4.55,;2.44,-6.09,;3.77,-6.86,;5.11,-6.09,;5.15,-4.53,;6.49,-3.76,;6.49,-2.22,;7.82,-4.53,;1.1,-6.86,;-.23,-6.09,;-1.6,-6.85,;-1.59,-8.42,;-.24,-9.21,;1.1,-8.4,)|	InChI=1S/C37H53N5O4/c1-37(2,3)27-7-4-25(5-8-27)32-22-26(6-11-33(32)46-30-12-15-40-24-30)36(44)42-18-13-29(14-19-42)45-34-23-28(9-10-31(34)35(38)43)41-20-16-39-17-21-41/h6,9-11,22-23,25,27,29-30,39-40H,4-5,7-8,12-21,24H2,1-3H3,(H2,38,43)/p+2	ZOEKLQXTKHNICV-UHFFFAOYSA-P	682697	US20240208940, Example 41	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<20000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682697	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682697&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055925	503272117							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425609	CC(C)(C)C1CCC(CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C(N)=O)N1CC[NH2+]CC1 |r,w:7.10,4.3,wD:17.18,(6.44,7,;5.11,7.77,;5.11,9.31,;6.44,8.54,;3.77,7,;3.77,5.46,;2.44,4.69,;1.1,5.46,;1.1,7,;2.44,7.77,;-.23,4.69,;-.23,3.15,;-1.56,2.38,;-2.9,3.15,;-2.9,4.69,;-1.56,5.46,;-1.56,7,;-2.9,7.77,;-3.06,9.3,;-4.62,9.66,;-5.39,8.29,;-4.29,7.1,;-1.56,.84,;-2.9,.07,;-.23,.07,;-.23,-1.47,;1.1,-2.24,;2.44,-1.47,;2.44,.07,;1.1,.84,;3.77,-2.24,;3.77,-3.78,;2.44,-4.55,;2.44,-6.09,;3.77,-6.86,;5.11,-6.09,;5.15,-4.53,;6.49,-3.76,;6.49,-2.22,;7.82,-4.53,;1.1,-6.86,;-.23,-6.09,;-1.6,-6.85,;-1.59,-8.42,;-.24,-9.21,;1.1,-8.4,)|	InChI=1S/C37H53N5O4/c1-37(2,3)27-7-4-25(5-8-27)32-22-26(6-11-33(32)46-30-12-15-40-24-30)36(44)42-18-13-29(14-19-42)45-34-23-28(9-10-31(34)35(38)43)41-20-16-39-17-21-41/h6,9-11,22-23,25,27,29-30,39-40H,4-5,7-8,12-21,24H2,1-3H3,(H2,38,43)/p+2	ZOEKLQXTKHNICV-UHFFFAOYSA-P	682697	US20240208940, Example 41	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<20000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682697	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682697&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055925	503272117							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425610	CNC(=O)c1ccc(cc1OC1CCN(CC1)C(=O)c1ccc(O[C@H]2CC[NH2+]C2)c(c1)C1CCC(CC1)C(C)(C)C)N1CC[NH2+]CC1 |r,w:31.34,34.41,wU:24.25,(8.25,-27.41,;8.25,-25.87,;6.92,-25.1,;6.92,-23.56,;5.59,-25.87,;5.54,-27.44,;4.21,-28.21,;2.87,-27.44,;2.87,-25.9,;4.21,-25.13,;4.21,-23.59,;2.87,-22.82,;1.54,-23.59,;.2,-22.82,;.2,-21.28,;1.54,-20.51,;2.87,-21.28,;-1.13,-20.51,;-2.46,-21.28,;-1.13,-18.97,;-2.46,-18.2,;-2.46,-16.66,;-1.13,-15.89,;-1.28,-14.5,;-2.46,-13.58,;-2.62,-12.05,;-1.16,-11.37,;-.13,-12.55,;-.96,-13.94,;.2,-16.66,;.2,-18.2,;1.54,-15.89,;2.87,-16.66,;4.21,-15.89,;4.21,-14.35,;2.87,-13.58,;1.54,-14.35,;5.54,-13.58,;6.87,-14.35,;5.54,-12.04,;6.87,-12.81,;1.54,-28.21,;.2,-27.44,;-1.17,-28.2,;-1.16,-29.77,;.19,-30.56,;1.54,-29.75,)|	InChI=1S/C38H55N5O4/c1-38(2,3)28-8-5-26(6-9-28)33-23-27(7-12-34(33)47-31-13-16-41-25-31)37(45)43-19-14-30(15-20-43)46-35-24-29(42-21-17-40-18-22-42)10-11-32(35)36(44)39-4/h7,10-12,23-24,26,28,30-31,40-41H,5-6,8-9,13-22,25H2,1-4H3,(H,39,44)/p+2	WLBYRAHGLNYMGD-UHFFFAOYSA-P	682698	US20240208940, Example 42	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<50000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682698	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682698&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055926	503272118							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425611	CNC(=O)c1ccc(cc1OC1CCN(CC1)C(=O)c1ccc(O[C@H]2CC[NH2+]C2)c(c1)C1CCC(CC1)C(C)(C)C)N1CC[NH2+]CC1 |r,w:31.34,34.41,wU:24.25,(8.25,-27.41,;8.25,-25.87,;6.92,-25.1,;6.92,-23.56,;5.59,-25.87,;5.54,-27.44,;4.21,-28.21,;2.87,-27.44,;2.87,-25.9,;4.21,-25.13,;4.21,-23.59,;2.87,-22.82,;1.54,-23.59,;.2,-22.82,;.2,-21.28,;1.54,-20.51,;2.87,-21.28,;-1.13,-20.51,;-2.46,-21.28,;-1.13,-18.97,;-2.46,-18.2,;-2.46,-16.66,;-1.13,-15.89,;-1.28,-14.5,;-2.46,-13.58,;-2.62,-12.05,;-1.16,-11.37,;-.13,-12.55,;-.96,-13.94,;.2,-16.66,;.2,-18.2,;1.54,-15.89,;2.87,-16.66,;4.21,-15.89,;4.21,-14.35,;2.87,-13.58,;1.54,-14.35,;5.54,-13.58,;6.87,-14.35,;5.54,-12.04,;6.87,-12.81,;1.54,-28.21,;.2,-27.44,;-1.17,-28.2,;-1.16,-29.77,;.19,-30.56,;1.54,-29.75,)|	InChI=1S/C38H55N5O4/c1-38(2,3)28-8-5-26(6-9-28)33-23-27(7-12-34(33)47-31-13-16-41-25-31)37(45)43-19-14-30(15-20-43)46-35-24-29(42-21-17-40-18-22-42)10-11-32(35)36(44)39-4/h7,10-12,23-24,26,28,30-31,40-41H,5-6,8-9,13-22,25H2,1-4H3,(H,39,44)/p+2	WLBYRAHGLNYMGD-UHFFFAOYSA-P	682698	US20240208940, Example 42	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<50000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682698	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682698&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055926	503272118							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425612	CN(C)C(=O)c1ccc(cc1OC1CCN(CC1)C(=O)c1ccc(O[C@H]2CC[NH2+]C2)c(c1)C1CCC(CC1)C(C)(C)C)N1CC[NH2+]CC1 |r,w:32.35,35.42,wD:25.26,(8.02,-3.98,;6.69,-4.75,;6.69,-6.29,;5.35,-3.98,;5.35,-2.44,;4.02,-4.75,;3.97,-6.32,;2.64,-7.09,;1.3,-6.32,;1.3,-4.78,;2.64,-4.01,;2.64,-2.47,;1.3,-1.7,;-.03,-2.47,;-1.36,-1.7,;-1.36,-.16,;-.03,.61,;1.3,-.16,;-2.7,.61,;-4.03,-.16,;-2.7,2.15,;-4.03,2.92,;-4.03,4.46,;-2.7,5.23,;-2.7,6.77,;-4.03,7.54,;-4.19,9.08,;-5.76,9.43,;-6.52,8.07,;-5.43,6.88,;-1.36,4.46,;-1.36,2.92,;-.03,5.23,;1.3,4.46,;2.64,5.23,;2.64,6.77,;1.3,7.54,;-.03,6.77,;3.97,7.54,;5.31,6.77,;3.97,9.08,;5.31,8.31,;-.03,-7.09,;-1.36,-6.32,;-2.74,-7.07,;-2.73,-8.64,;-1.37,-9.44,;-.03,-8.63,)|	InChI=1S/C39H57N5O4/c1-39(2,3)29-9-6-27(7-10-29)34-24-28(8-13-35(34)48-32-14-17-41-26-32)37(45)44-20-15-31(16-21-44)47-36-25-30(43-22-18-40-19-23-43)11-12-33(36)38(46)42(4)5/h8,11-13,24-25,27,29,31-32,40-41H,6-7,9-10,14-23,26H2,1-5H3/p+2	AKGZQLRCBRPFJM-UHFFFAOYSA-P	682699	US20240208940, Example 43	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			 100000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682699	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682699&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055927	503272119							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425613	CN(C)C(=O)c1ccc(cc1OC1CCN(CC1)C(=O)c1ccc(O[C@H]2CC[NH2+]C2)c(c1)C1CCC(CC1)C(C)(C)C)N1CC[NH2+]CC1 |r,w:32.35,35.42,wD:25.26,(8.02,-3.98,;6.69,-4.75,;6.69,-6.29,;5.35,-3.98,;5.35,-2.44,;4.02,-4.75,;3.97,-6.32,;2.64,-7.09,;1.3,-6.32,;1.3,-4.78,;2.64,-4.01,;2.64,-2.47,;1.3,-1.7,;-.03,-2.47,;-1.36,-1.7,;-1.36,-.16,;-.03,.61,;1.3,-.16,;-2.7,.61,;-4.03,-.16,;-2.7,2.15,;-4.03,2.92,;-4.03,4.46,;-2.7,5.23,;-2.7,6.77,;-4.03,7.54,;-4.19,9.08,;-5.76,9.43,;-6.52,8.07,;-5.43,6.88,;-1.36,4.46,;-1.36,2.92,;-.03,5.23,;1.3,4.46,;2.64,5.23,;2.64,6.77,;1.3,7.54,;-.03,6.77,;3.97,7.54,;5.31,6.77,;3.97,9.08,;5.31,8.31,;-.03,-7.09,;-1.36,-6.32,;-2.74,-7.07,;-2.73,-8.64,;-1.37,-9.44,;-.03,-8.63,)|	InChI=1S/C39H57N5O4/c1-39(2,3)29-9-6-27(7-10-29)34-24-28(8-13-35(34)48-32-14-17-41-26-32)37(45)44-20-15-31(16-21-44)47-36-25-30(43-22-18-40-19-23-43)11-12-33(36)38(46)42(4)5/h8,11-13,24-25,27,29,31-32,40-41H,6-7,9-10,14-23,26H2,1-5H3/p+2	AKGZQLRCBRPFJM-UHFFFAOYSA-P	682699	US20240208940, Example 43	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		 81000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682699	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682699&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055927	503272119							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425614	CC(C)(C)[C@@H]1CC[C@@H](CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C#N)N1CC[NH2+]CC1 |r,wU:7.10,4.3,wD:17.18,(6.14,28.45,;4.81,29.22,;4.81,30.76,;6.14,29.99,;3.47,28.45,;2.14,29.22,;.81,28.45,;.81,26.91,;2.14,26.14,;3.47,26.91,;-.53,26.14,;-.53,24.6,;-1.86,23.83,;-3.19,24.6,;-3.19,26.14,;-1.86,26.91,;-1.86,28.45,;-3.19,29.22,;-3.35,30.75,;-4.92,31.11,;-5.69,29.74,;-4.59,28.55,;-1.86,22.29,;-3.19,21.52,;-.53,21.52,;-.53,19.98,;.81,19.21,;2.14,19.98,;2.14,21.52,;.81,22.29,;3.47,19.21,;3.47,17.67,;2.14,16.9,;2.14,15.36,;3.47,14.59,;4.81,15.36,;4.86,16.93,;6.19,17.7,;7.52,18.47,;.81,14.59,;-.53,15.36,;-1.9,14.6,;-1.89,13.03,;-.54,12.24,;.81,13.05,)|	InChI=1S/C37H51N5O3/c1-37(2,3)29-8-4-26(5-9-29)33-22-27(7-11-34(33)45-32-12-15-40-25-32)36(43)42-18-13-31(14-19-42)44-35-23-30(10-6-28(35)24-38)41-20-16-39-17-21-41/h6-7,10-11,22-23,26,29,31-32,39-40H,4-5,8-9,12-21,25H2,1-3H3/p+2	QQTSKTWBOQEFNY-UHFFFAOYSA-P	682700	US20240208940, Example 44	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<2000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682700	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682700&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055921	503272120							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425615	CC(C)(C)[C@@H]1CC[C@@H](CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C#N)N1CC[NH2+]CC1 |r,wU:7.10,4.3,wD:17.18,(6.14,28.45,;4.81,29.22,;4.81,30.76,;6.14,29.99,;3.47,28.45,;2.14,29.22,;.81,28.45,;.81,26.91,;2.14,26.14,;3.47,26.91,;-.53,26.14,;-.53,24.6,;-1.86,23.83,;-3.19,24.6,;-3.19,26.14,;-1.86,26.91,;-1.86,28.45,;-3.19,29.22,;-3.35,30.75,;-4.92,31.11,;-5.69,29.74,;-4.59,28.55,;-1.86,22.29,;-3.19,21.52,;-.53,21.52,;-.53,19.98,;.81,19.21,;2.14,19.98,;2.14,21.52,;.81,22.29,;3.47,19.21,;3.47,17.67,;2.14,16.9,;2.14,15.36,;3.47,14.59,;4.81,15.36,;4.86,16.93,;6.19,17.7,;7.52,18.47,;.81,14.59,;-.53,15.36,;-1.9,14.6,;-1.89,13.03,;-.54,12.24,;.81,13.05,)|	InChI=1S/C37H51N5O3/c1-37(2,3)29-8-4-26(5-9-29)33-22-27(7-11-34(33)45-32-12-15-40-25-32)36(43)42-18-13-31(14-19-42)44-35-23-30(10-6-28(35)24-38)41-20-16-39-17-21-41/h6-7,10-11,22-23,26,29,31-32,39-40H,4-5,8-9,12-21,25H2,1-3H3/p+2	QQTSKTWBOQEFNY-UHFFFAOYSA-P	682700	US20240208940, Example 44	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<2000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682700	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682700&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055921	503272120							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425616	CC(C)(C)[C@H]1CC[C@@H](CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C#N)N1CC[NH2+]CC1 |r,wU:7.10,wD:17.18,4.3,(6.14,28.45,;4.81,29.22,;4.81,30.76,;6.14,29.99,;3.47,28.45,;2.14,29.22,;.81,28.45,;.81,26.91,;2.14,26.14,;3.47,26.91,;-.53,26.14,;-.53,24.6,;-1.86,23.83,;-3.19,24.6,;-3.19,26.14,;-1.86,26.91,;-1.86,28.45,;-3.19,29.22,;-3.35,30.75,;-4.92,31.11,;-5.69,29.74,;-4.59,28.55,;-1.86,22.29,;-3.19,21.52,;-.53,21.52,;-.53,19.98,;.81,19.21,;2.14,19.98,;2.14,21.52,;.81,22.29,;3.47,19.21,;3.47,17.67,;2.14,16.9,;2.14,15.36,;3.47,14.59,;4.81,15.36,;4.86,16.93,;6.19,17.7,;7.52,18.47,;.81,14.59,;-.53,15.36,;-1.9,14.6,;-1.89,13.03,;-.54,12.24,;.81,13.05,)|	InChI=1S/C37H51N5O3/c1-37(2,3)29-8-4-26(5-9-29)33-22-27(7-11-34(33)45-32-12-15-40-25-32)36(43)42-18-13-31(14-19-42)44-35-23-30(10-6-28(35)24-38)41-20-16-39-17-21-41/h6-7,10-11,22-23,26,29,31-32,39-40H,4-5,8-9,12-21,25H2,1-3H3/p+2	QQTSKTWBOQEFNY-UHFFFAOYSA-P	682701	US20240208940, Example 45	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]			<4000							US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682701	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682701&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055921	503272121							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																										
1425617	CC(C)(C)[C@H]1CC[C@@H](CC1)c1cc(ccc1O[C@H]1CC[NH2+]C1)C(=O)N1CCC(CC1)Oc1cc(ccc1C#N)N1CC[NH2+]CC1 |r,wU:7.10,wD:17.18,4.3,(6.14,28.45,;4.81,29.22,;4.81,30.76,;6.14,29.99,;3.47,28.45,;2.14,29.22,;.81,28.45,;.81,26.91,;2.14,26.14,;3.47,26.91,;-.53,26.14,;-.53,24.6,;-1.86,23.83,;-3.19,24.6,;-3.19,26.14,;-1.86,26.91,;-1.86,28.45,;-3.19,29.22,;-3.35,30.75,;-4.92,31.11,;-5.69,29.74,;-4.59,28.55,;-1.86,22.29,;-3.19,21.52,;-.53,21.52,;-.53,19.98,;.81,19.21,;2.14,19.98,;2.14,21.52,;.81,22.29,;3.47,19.21,;3.47,17.67,;2.14,16.9,;2.14,15.36,;3.47,14.59,;4.81,15.36,;4.86,16.93,;6.19,17.7,;7.52,18.47,;.81,14.59,;-.53,15.36,;-1.9,14.6,;-1.89,13.03,;-.54,12.24,;.81,13.05,)|	InChI=1S/C37H51N5O3/c1-37(2,3)29-8-4-26(5-9-29)33-22-27(7-11-34(33)45-32-12-15-40-25-32)36(43)42-18-13-31(14-19-42)44-35-23-30(10-6-28(35)24-38)41-20-16-39-17-21-41/h6-7,10-11,22-23,26,29,31-32,39-40H,4-5,8-9,12-21,25H2,1-3H3/p+2	QQTSKTWBOQEFNY-UHFFFAOYSA-P	682701	US20240208940, Example 45	Catenin beta -1 [E155A]/B-Cell CLL/Lymphoma 9 Protein [350-375]/Cadherin-1 [824-877]		<4000								US Patent		10.7270/Q2CC14ZD		aid1963902	US20240208940	JI, H	6/27/2024	10/4/2024	H. Lee Moffitt Cancer Center and Research Institute	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=682701	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=407&target=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=682701&enzyme=Catenin+beta+-1+%5BE155A%5D%2FB-Cell+CLL%2FLymphoma+9+Protein+%5B350-375%5D%2FCadherin-1+%5B824-877%5D&column=ki&startPg=0&Increment=50&submit=Search			172055921	503272121							3	MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPALTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL	3TX7,2BCT,3BCT,4ONS,1DOW,6M94,6M93,6M92,6M90,1P22,2G57	Catenin beta-1	CTNB1_HUMAN	P35222	A8K1L7 Q8NEW9 Q8NI94 Q9H391							GLSQEQLEHRERSLQTLRDIQRMLFP		B-cell CLL/lymphoma 9 protein	BCL9_HUMAN	O00512	Q5T489							APPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYG		Cadherin-1	CADH1_HUMAN	P12830	A8K1U7 Q13799 Q14216 Q15855 Q16194 Q4PJ14 Q9UII8